T1	Participants 130 150	Helicobacter pylori.
T2	Participants 186 210	Helicobacter pylori (HP)
T3	Participants 270 291	HP-infected patients.
T4	Participants 443 468	treatment-naive patients.
T5	Participants 477 637	Patients with a diagnosis of HP gastritis or peptic ulcer disease confirmed using endoscopy and stool antigen testing were eligible for inclusion in this study.
T6	Participants 642 650	patients
T7	Participants 729 737	Patients
T8	Participants 1802 1833	HP in treatment-naive patients.
